Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2017 | 1 |
2018 | 1 |
2019 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.
Brain. 2023 Feb 13;146(2):668-677. doi: 10.1093/brain/awac252.
Brain. 2023.
PMID: 35857854
[Treatment evaluation in patients with 5q-associated spinal muscular atrophy : Real-world experience].
Walter MC, Dräger B, Günther R, Hermann A, Hagenacker T, Kleinschnitz C, Löscher W, Meyer T, Schrank B, Schwersenz I, Wurster CD, Ludolph AC, Kirschner J.
Walter MC, et al. Among authors: schwersenz i.
Nervenarzt. 2019 Apr;90(4):343-351. doi: 10.1007/s00115-018-0653-7.
Nervenarzt. 2019.
PMID: 30617569
Review.
German.
Item in Clipboard
Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy.
Schorling DC, Kölbel H, Hentschel A, Pechmann A, Meyer N, Wirth B, Rombo R; SMArtCARE consortium; Sickmann A, Kirschner J, Schara-Schmidt U, Lochmüller H, Roos A.
Schorling DC, et al.
Eur J Neurol. 2022 Jul;29(7):2084-2096. doi: 10.1111/ene.15331. Epub 2022 May 4.
Eur J Neurol. 2022.
PMID: 35318785
Item in Clipboard
SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy.
Pechmann A, König K, Bernert G, Schachtrup K, Schara U, Schorling D, Schwersenz I, Stein S, Tassoni A, Vogt S, Walter MC, Lochmüller H, Kirschner J.
Pechmann A, et al. Among authors: schwersenz i.
Orphanet J Rare Dis. 2019 Jan 21;14(1):18. doi: 10.1186/s13023-019-0998-4.
Orphanet J Rare Dis. 2019.
PMID: 30665421
Free PMC article.
Item in Clipboard
Position Statement: Sharing of Clinical Research Data in Spinal Muscular Atrophy to Accelerate Research and Improve Outcomes for Patients.
Lochmüller H, Evans D, Farwell W, Finkel R, Goemans N, de Lemus M, Matyushenko V, Muntoni F, Ouillade MC, Schwersenz I, Wilson P.
Lochmüller H, et al. Among authors: schwersenz i.
J Neuromuscul Dis. 2018;5(2):131-133. doi: 10.3233/JND-180325.
J Neuromuscul Dis. 2018.
PMID: 29865093
Free PMC article.
No abstract available.
Item in Clipboard
Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients.
Rouault F, Christie-Brown V, Broekgaarden R, Gusset N, Henderson D, Marczuk P, Schwersenz I, Bellis G, Cottet C.
Rouault F, et al. Among authors: schwersenz i.
Neuromuscul Disord. 2017 May;27(5):428-438. doi: 10.1016/j.nmd.2017.01.018. Epub 2017 Feb 3.
Neuromuscul Disord. 2017.
PMID: 28237437
Item in Clipboard
SMA-EUROPE workshop report: Opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe.
Kayadjanian N, Burghes A, Finkel RS, Mercuri E, Rouault F, Schwersenz I, Talbot K.
Kayadjanian N, et al. Among authors: schwersenz i.
Orphanet J Rare Dis. 2013 Mar 20;8:44. doi: 10.1186/1750-1172-8-44.
Orphanet J Rare Dis. 2013.
PMID: 23514578
Free PMC article.
Item in Clipboard
Cite
Cite